News

America’s obesity crisis extends beyond humans — studies suggest that around 60% of dogs and cats nationwide are overweight.
Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.
The drug is available as a weight-loss medication under the brand name Wegovy and will now also be sold directly to diabetes patients ...
GoodRx and Novo Nordisk launch a $499 monthly self-pay option for Ozempic and Wegovy, expanding access at 70,000 pharmacies ...
The weight loss injectable Ozempic has faced several lawsuits in 2025 from people who had a negative experience with the ...
Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for ...
The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...
Novo Nordisk is shaking up the prescription drug market by slashing the price of Ozempic for uninsured Americans. The company announced that patients who pay out of pocket can now […] The post Ozempic ...